Non-cyclic nucleotide EPAC1 activators suppress lipopolysaccharide-regulated gene expression, signalling and intracellular communication in differentiated macrophage-like THP-1 cells

Wiejak, Jolanta and Murphy, Fiona A. and Barker, Graeme and Maffia, Pasquale and Yarwood, Stephen J. (2024) Non-cyclic nucleotide EPAC1 activators suppress lipopolysaccharide-regulated gene expression, signalling and intracellular communication in differentiated macrophage-like THP-1 cells. Cellular Signalling, 124. 111444. ISSN 1873-3913 (https://doi.org/10.1016/j.cellsig.2024.111444)

[thumbnail of Wiejak-etal-CS-2024-Non-cyclic-nucleotide-EPAC1-activators-suppress-lipopolysaccharide-regulated-gene-expression]
Preview
 Text. Filename: Wiejak-etal-CS-2024-Non-cyclic-nucleotide-EPAC1-activators-suppress-lipopolysaccharide-regulated-gene-expression.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (8MB)| Preview

Abstract

This study explores the anti-inflammatory effects of non-cyclic nucleotide EPAC1 activators, PW0577 and SY007, on lipopolysaccharide (LPS)-induced responses in differentiated THP-1 macrophage-like cells. Both activators were found to selectively activate EPAC1 in THP-1 macrophages, leading to the activation of the key down-stream effector, Rap1. RNA sequencing analysis of LPS-stimulated THP-1 macrophages, revealed that treatment with PW0577 or SY007 significantly modulates gene expression related to fibrosis and inflammation, including the suppression of NLRP3, IL-1β, and caspase 1 protein expression in LPS-stimulated cells. Notably, these effects were independent of p65 NFκB phosphorylation at Serine 536, indicating a distinct mechanism of action. The study further identified a shared influence of both activators on LPS signalling pathways, particularly impacting extracellular matrix (ECM) components and NFκB-regulated genes. Additionally, in a co-culture model involving THP-1 macrophages, vascular smooth muscle cells, and human coronary artery endothelial cells, EPAC1 activators modulated immune-vascular interactions, suggesting a broader role in regulating cellular communication between macrophages and endothelial cells. These findings enhance our understanding of EPAC1's role in inflammation and propose EPAC1 activators as potential therapeutic agents for treating inflammatory and fibrotic conditions through targeted modulation of Rap1 and associated signalling pathways.

ORCID iDs

Wiejak, Jolanta, Murphy, Fiona A. ORCID logoORCID: https://orcid.org/0000-0001-7925-0632, Barker, Graeme, Maffia, Pasquale and Yarwood, Stephen J.;
CORE (COnnecting REpositories)